Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease
Identifieur interne : 002996 ( Main/Curation ); précédent : 002995; suivant : 002997Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease
Auteurs : S M Hague [Royaume-Uni] ; S. Klaffke [Royaume-Uni] ; O. Bandmann [Royaume-Uni]Source :
- Journal of Neurology, Neurosurgery & Psychiatry [ 0022-3050 ] ; 2005-08.
English descriptors
- KwdEn :
Abstract
Parkinson’s disease and Huntington’s disease are both model diseases. Parkinson’s disease is the most common of several akinetic-rigid syndromes and Huntington’s disease is only one of an ever growing number of trinucleotide repeat disorders. Molecular genetic studies and subsequent molecular biological studies have provided fascinating new insights into the pathogenesis of both disorders and there is now real hope for disease modifying treatment in the not too distant future for patients with Parkinson’s disease or Huntington’s disease.
Url:
DOI: 10.1136/jnnp.2004.060186
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002D74
Links to Exploration step
ISTEX:D540A881E7B65944EF4F038D17C4DC24937CAE4CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease</title><author><name sortKey="Hague, S M" sort="Hague, S M" uniqKey="Hague S" first="S M" last="Hague">S M Hague</name><affiliation wicri:level="1"><mods:affiliation>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield</wicri:regionArea></affiliation></author><author><name sortKey="Klaffke, S" sort="Klaffke, S" uniqKey="Klaffke S" first="S" last="Klaffke">S. Klaffke</name><affiliation wicri:level="1"><mods:affiliation>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield</wicri:regionArea></affiliation></author><author><name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O" last="Bandmann">O. Bandmann</name><affiliation wicri:level="1"><mods:affiliation>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D540A881E7B65944EF4F038D17C4DC24937CAE4C</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1136/jnnp.2004.060186</idno><idno type="url">https://api.istex.fr/document/D540A881E7B65944EF4F038D17C4DC24937CAE4C/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002D74</idno><idno type="wicri:Area/Main/Curation">002996</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease</title><author><name sortKey="Hague, S M" sort="Hague, S M" uniqKey="Hague S" first="S M" last="Hague">S M Hague</name><affiliation wicri:level="1"><mods:affiliation>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield</wicri:regionArea></affiliation></author><author><name sortKey="Klaffke, S" sort="Klaffke, S" uniqKey="Klaffke S" first="S" last="Klaffke">S. Klaffke</name><affiliation wicri:level="1"><mods:affiliation>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield</wicri:regionArea></affiliation></author><author><name sortKey="Bandmann, O" sort="Bandmann, O" uniqKey="Bandmann O" first="O" last="Bandmann">O. Bandmann</name><affiliation wicri:level="1"><mods:affiliation>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield, UK</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Academic Neurology Unit, Division of Genomic Medicine, University of Sheffield</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="ISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2005-08">2005-08</date><biblScope unit="volume">76</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1058">1058</biblScope></imprint><idno type="ISSN">0022-3050</idno></series><idno type="istex">D540A881E7B65944EF4F038D17C4DC24937CAE4C</idno><idno type="DOI">10.1136/jnnp.2004.060186</idno><idno type="href">jnnp-76-1058.pdf</idno><idno type="PMID">16024878</idno><idno type="local">0761058</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3050</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>A-S, α-synuclein</term><term>CBP, CREB binding protein</term><term>COX2, cyclo-oxygenase 2</term><term>Huntington’s disease</term><term>MPTP, 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine</term><term>Parkinson’s disease</term><term>genetics</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson’s disease and Huntington’s disease are both model diseases. Parkinson’s disease is the most common of several akinetic-rigid syndromes and Huntington’s disease is only one of an ever growing number of trinucleotide repeat disorders. Molecular genetic studies and subsequent molecular biological studies have provided fascinating new insights into the pathogenesis of both disorders and there is now real hope for disease modifying treatment in the not too distant future for patients with Parkinson’s disease or Huntington’s disease.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002996 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002996 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Curation
|type= RBID
|clé= ISTEX:D540A881E7B65944EF4F038D17C4DC24937CAE4C
|texte= Neurodegenerative disorders: Parkinson’s disease and Huntington’s disease
}}
| This area was generated with Dilib version V0.6.23. |  |